109 related articles for article (PubMed ID: 10214370)
41. Psychosocial issues associated with increased breast and ovarian cancer risk: findings from focus groups.
Pasacreta JV
Arch Psychiatr Nurs; 1999 Jun; 13(3):127-36. PubMed ID: 10389341
[TBL] [Abstract][Full Text] [Related]
42. Concerns of women presenting to a comprehensive cancer centre for genetic cancer risk assessment.
MacDonald DJ; Choi J; Ferrell B; Sand S; McCaffrey S; Blazer KR; Grant M; Weitzel JN
J Med Genet; 2002 Jul; 39(7):526-30. PubMed ID: 12114489
[No Abstract] [Full Text] [Related]
43. What do ratings of cancer-specific distress mean among women at high risk of breast and ovarian cancer?
Coyne JC; Kruus L; Racioppo M; Calzone KA; Armstrong K
Am J Med Genet A; 2003 Jan; 116A(3):222-8. PubMed ID: 12503096
[TBL] [Abstract][Full Text] [Related]
44. Measurement of psychological factors associated with genetic testing for hereditary breast, ovarian and colon cancers.
Vadaparampil ST; Ropka M; Stefanek ME
Fam Cancer; 2005; 4(2):195-206. PubMed ID: 15951974
[TBL] [Abstract][Full Text] [Related]
45. [Problem of the hereditary breast cancer screening; including the genetic diagnosis].
Saito H; Miki Y
Nihon Rinsho; 2012 Sep; 70 Suppl 7():480-6. PubMed ID: 23350446
[No Abstract] [Full Text] [Related]
46. Testing for a troublesome gene.
Titus K
CAP Today; 1996 Apr; 10(4):14-6, 18, 20 passim. PubMed ID: 10160265
[No Abstract] [Full Text] [Related]
47. Estimating risk using multi-gene panel testing; do negative results change the risk?
Sorscher SM
J Hum Genet; 2017 Feb; 62(2):339. PubMed ID: 27734838
[No Abstract] [Full Text] [Related]
48. Subjective versus objective risk in genetic counseling for hereditary breast and/or ovarian cancers.
Caruso A; Vigna C; Marozzo B; Sega FM; Sperduti I; Cognetti F; Savarese A
J Exp Clin Cancer Res; 2009 Dec; 28(1):157. PubMed ID: 20025726
[TBL] [Abstract][Full Text] [Related]
49. [Hereditary breast and/or ovarian cancer: consequences for family relations].
Frets PG; Dudok de Wit AC; Tibben A; Meijers-Heijboer EJ; Klijn JG; Niermeijer MF
Oncologica; 1997 Feb; 14(1):47-9. PubMed ID: 9418545
[No Abstract] [Full Text] [Related]
50. Genetic susceptibility testing. A therapeutic illusion.
Freedman TG
Cancer; 1997 Jun; 79(11):2063-5; discussion 2066. PubMed ID: 9179051
[No Abstract] [Full Text] [Related]
51. A community based study on intentions regarding predictive testing for hereditary breast cancer.
Welkenhuysen M; Evers-Kiebooms G; Decruyenaere M; Claes E; Denayer L
J Med Genet; 2001 Aug; 38(8):540-7. PubMed ID: 11494966
[No Abstract] [Full Text] [Related]
52. Genetic heterogeneity of breast-ovarian cancer revisited. Breast Cancer Linkage Consortium.
Narod S; Ford D; Devilee P; Barkardottir RB; Eyfjord J; Lenoir G; Serova O; Easton D; Goldgar D
Am J Hum Genet; 1995 Oct; 57(4):957-8. PubMed ID: 7573057
[No Abstract] [Full Text] [Related]
53. Time elapsing from cancer diagnosis and anxiety in women attending cancer genetic clinics.
Julian-Reynier C; Eisinger F; Chabal F; Aurran Y; Bignon YJ; Nogues C; Machelard M; Maugard C; Vennin P; Sobol H
Oncol Rep; 1998; 5(4):885-8. PubMed ID: 9625838
[TBL] [Abstract][Full Text] [Related]
54. Comment on "Myriad genetics: in the eye of the policy storm".
Palombi L
Genet Med; 2010 Jul; 12(7):471; author reply 471-2. PubMed ID: 20631548
[No Abstract] [Full Text] [Related]
55. The emerging roles of screening and prevention in women's cancer.
Muggia FM
Oncologist; 2004; 9(2):228-31. PubMed ID: 15047928
[No Abstract] [Full Text] [Related]
56. Screening and treatment of distress.
Paterson AG; Trask PC; Schwartz SM; Deaner SL; Riba M; Holland J; Fleishman SB; Breitbart W
J Consult Clin Psychol; 2001 Apr; 69(2):339. PubMed ID: 11393611
[No Abstract] [Full Text] [Related]
57. The future of breast and ovarian cancer clinics.
Campbell H; MacKay J; Porteous M
BMJ; 1995 Dec; 311(7020):1584-5. PubMed ID: 8555791
[No Abstract] [Full Text] [Related]
58. Risk of breast cancer in offspring of male breast-cancer patients.
Storm HH; Olsen J
Lancet; 1999 Jan; 353(9148):209. PubMed ID: 9923884
[No Abstract] [Full Text] [Related]
59. A terrible beauty: a physician's story of ovarian cancer.
Spano LJ
Can Fam Physician; 2007 Jun; 53(6):983-5. PubMed ID: 17872763
[No Abstract] [Full Text] [Related]
60. London hospital widens access to genetic tests for ovarian cancer.
Arie S
BMJ; 2014 Jan; 348():g1179. PubMed ID: 24474303
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
